3rd International Genetics and Molecular Biology Conference

Omer Saka

Omer Saka

Consultant
Deloitte
Belgium

Biography

Omer Saka provide consultancy to global life sciences companies in various projects (clinical observational studies, health economic evaluations, literature reviews) in several disease domains (oncology, cardiovascular, diabetes and infection diseases), for a wide range of clients from Belgium, Holland, UK, Spain, Turkey, US, Switzerland. Lead the health economics and decision modelling practices at the National Audit Office of England, auditing government policy on health. Lead and published economic research studies and worked on the establishment of the UK National Stroke Strategy in 2007. Managed projects on hospital management, project tracking and progress monitoring, and technical assessments for the pharmaceutical sector and healthcare industry. Performed high volume research on utilization of pharmaceutical services in the first wave EU accession countries, US Medicare outpatient pharmaceutical benefits coverage, complementary and alternative medicines services in UK and Germany, reimbursement policy in Turkey. He published in several journals on these subjects. He was an advisor to the Health and Living Conditions Network of the European Observatory on Health Systems and Policies, Social Situation in the European Union He is a founding member of the Turkish Association for Health Economics and Health Policy


Research Interest

Health economics and policy, health technology assessment, clinical research, comparative effectiveness research, process modelling and optimisation research, pricing and reimbursement

Related Conferenes

Conference Highlights